Condensed Statements of Operations and Comprehensive Loss (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Operating expenses:
Research and development	$ 3,088,373	$ 78,731	$ 7,815,466	$ 320,558
General and administrative	732,800	406,862	2,420,167	700,489
Total operating expenses	3,821,173	485,593	10,235,633	1,021,047
Loss from operations	(3,821,173)	(485,593)	(10,235,633)	(1,021,047)
Other income (expense):
Interest income	1,725	629	8,995	2,850
Interest expense	(5,906)	(39,940)	(101,240)	(119,570)
Change in fair value of warrant liability		39,000		(82,000)
Total other income (expense)	(4,181)	(311)	(92,245)	(198,720)
Net loss and comprehensive loss	$ (3,825,354)	$ (485,904)	$ (10,327,878)	$ (1,219,767)
Net loss per common share, basic and diluted	$ (0.63)	$ (0.41)	$ (1.71)	$ (1.06)
Weighted-average shares used to compute basic and diluted net loss per share	6,054,250	1,190,212	6,028,309	1,153,751